XRAY vs COO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

XRAY

46.6
AI Score
VS
COO Wins

COO

47.9
AI Score

Investment Advisor Scores

XRAY

47score
Recommendation
HOLD

COO

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XRAY COO Winner
Revenue 1.78B 2.11B COO
Net Income 27.00M 52.90M COO
Gross Margin 51.7% 67.9% COO
Net Margin 1.5% 2.5% COO
Operating Income 47.00M 181.80M COO
ROE 2.0% 0.6% XRAY
ROA 0.5% 0.4% XRAY
Total Assets 5.20B 12.48B COO
Cash 239.00M 138.80M XRAY
Debt/Equity 1.48 0.23 COO
Current Ratio 1.63 1.27 XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: -8.3% · 3M: +3.2% COO 1M: -29.7% · 3M: -20.1%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.7 · Price: $10.46

COO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 15

RSI (14): 14.7 · Price: $53.91

Fundamentals Snapshot

Metric XRAY COO
Market Cap
Forward P/E 6.9 10.8
Trailing P/E 21.8
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin 0.1% 0.0%
EPS -2.68 2.48
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, COO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.